- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Jeffrey S. Spigel (Jeff)
News 27 results
Recognition
December 14, 2022
King & Spalding Once Again Recognized on Global Competition Review’s GCR 100 List
Recognition
September 16, 2022
King & Spalding Recognized for its Leadership in Atlanta-Area Deals of the Year
In the News · Source: Law360, Law360 Tax Authority, The Deal, The American Lawyer and MarketScreener
August 1, 2022
K&S advises EVO Payments on its $4B acquisition by Global Payments
Cases & Deals
August 1, 2022
EVO to be Acquired by Global Payments in $4 Billion Transaction
Events 5 results
Conference
March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Insights 36 results
Client Alert
February 6, 2023
DOJ Alters Standards for Information Sharing in Healthcare
Client Alert
January 25, 2023
FTC Updates the Size of Transaction Thresholds for Premerger Notification Filings
Client Alert
January 9, 2023
FTC Cracks Down on Non-Competes
Client Alert
December 22, 2022
Venue Changes for State Antitrust Enforcement